Alnylam Pharmaceuticals | Należności Handlowe



Trade Debtors Zmiana Data
Acadia Pharmaceuticals USD 113.71M 9.02M 2025-03
Agios Pharmaceuticals USD 3.34M 765K 2025-03
Alnylam Pharmaceuticals USD 418.04M 12.73M 2025-03
Amgen USD 8.13B 1.35B 2025-03
Arrowhead Research USD 2.36M 135K 2025-03
BioMarin Pharmaceutical USD 739.18M 78.64M 2025-03
Incyte USD 823.13M 30.02M 2025-03
Ionis Pharmaceuticals USD 39.71M 52.48M 2025-03
Moderna USD 306M 286M 2025-03
Neurocrine Biosciences USD 479.1M 2M 2024-12
Novartis USD 7.56B 594M 2024-12
PTC Therapeutics USD 210.5M 51.94M 2025-03
Regeneron Pharmaceuticals USD 5.56B 650.9M 2025-03
Sanofi 10.63B 1.82B 2024-12
Sarepta Therapeutics USD 724.52M 74.8M 2025-03
Takeda JPY 725.25B 9.81B 2025-03
Tectonic Therapeutic USD 0 270K 2023-12
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12
Xencor USD 37.78M 23.06M 2025-03



Alnylam Pharmaceuticals Należności Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.